Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Daisuke Yabe & Yutaka Seino. (2016) Alogliptin for the treatment of type 2 diabetes: a drug safety evaluation. Expert Opinion on Drug Safety 15:2, pages 249-264.
Read now
Read now
Articles from other publishers (4)
Yarini Arrebola Sánchez, Fabiola Almeida García, Daniel Ojeda del Sol, Mario E. Valdés-Tresanco, Carlos David Ortiz, Belinda Sánchez Ramírez & Isel Pascual Alonso. (2023) Dipeptidyl peptidase IV: a multifunctional enzyme with implications in several pathologies including cancer. Physical Sciences Reviews 0:0.
Crossref
Crossref
·依明 依力汗. (2023) Molecular Mechanism of Dipeptidyl Peptidase-4 (DPP4) Promoting Oxidative Stress and Inflammatory Response of Adipocytes. Advances in Clinical Medicine 13:02, pages 2529-2935.
Crossref
Crossref
Jarir At Thobari, Lucia Krisdinarti, Dhite Nugroho, Jonathan Haposan, Isman Firdaus, Rr. Arum Ramadhyan Suryandani, Muhammad Munawar & Jimmy Agung. (2022) Cost-Effectiveness of Ticagrelor for Acute Coronary Disease to Prevent Cardiovascular Events in Three Hospitals in Indonesia. Open Access Macedonian Journal of Medical Sciences 10:A, pages 1211-1217.
Crossref
Crossref
Tianli Zhang, Xiang Tong, Shijie Zhang, Dongguang Wang, Lian Wang, Qian Wang & Hong Fan. (2021) The Roles of Dipeptidyl Peptidase 4 (DPP4) and DPP4 Inhibitors in Different Lung Diseases: New Evidence. Frontiers in Pharmacology 12.
Crossref
Crossref